Suppr超能文献

草药在青光眼治疗中的应用。

Herbal Medicines in Glaucoma Treatment.

机构信息

Yale University School of Medicine, New Haven, CT.

Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT.

出版信息

Yale J Biol Med. 2020 Jun 29;93(2):347-353. eCollection 2020 Jun.

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide. Optimizing treatment is important to protecting vision. The current standard of therapy for glaucoma involves lowering the intraocular pressure (IOP) through medical, laser, and/or surgical therapy. Nevertheless, there are an increasing number of glaucoma patients that use alternative medicines to treat their glaucoma or supplement their traditional glaucoma management. Ginkgo biloba, bilberry, and medical marijuana are amongst the most commonly used medicinal plants by glaucoma patients. We reviewed the literature to determine the benefits, safety, and efficacy of these herbal remedies. Though ginkgo biloba and bilberry may prevent or slow down retinal ganglion cell death, there is no evidence yet to suggest that they alter the course of glaucoma. Medical marijuana has shown IOP lowering effect in some individuals, but its short duration of action, significant adverse effects, and addictive potential have rendered it an inappropriate standard therapeutic agent for glaucoma. Larger studies with longer durations that investigate the effect of herbal medicines on the course of glaucoma in comparison to the current standard of care are needed to elucidate their benefits in glaucoma treatment.

摘要

青光眼是全球导致不可逆性失明的主要原因。优化治疗对于保护视力非常重要。目前,青光眼的标准治疗方法包括通过药物、激光和/或手术治疗降低眼内压(IOP)。然而,越来越多的青光眼患者使用替代药物来治疗他们的青光眼或补充他们的传统青光眼管理。银杏、越橘和医用大麻是青光眼患者最常使用的药用植物。我们查阅了文献,以确定这些草药的益处、安全性和疗效。尽管银杏和越橘可能预防或减缓视网膜神经节细胞的死亡,但目前尚无证据表明它们改变青光眼的病程。医用大麻在某些人中显示出降低眼压的效果,但由于其作用持续时间短、严重不良反应和潜在成瘾性,使其不适合作为青光眼的标准治疗药物。需要进行更大规模、更长时间的研究,以调查草药对青光眼病程的影响,并与当前的标准治疗方法进行比较,以阐明它们在青光眼治疗中的益处。

相似文献

1
Herbal Medicines in Glaucoma Treatment.
Yale J Biol Med. 2020 Jun 29;93(2):347-353. eCollection 2020 Jun.
2
Alternative therapy in glaucoma management: is there any role?
Indian J Ophthalmol. 2011 Jan;59 Suppl(Suppl1):S158-60. doi: 10.4103/0301-4738.73679.
3
Complementary and alternative medicine for glaucoma.
Surv Ophthalmol. 2001 Jul-Aug;46(1):43-55. doi: 10.1016/s0039-6257(01)00233-8.
4
Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update.
Nutrients. 2022 Jan 26;14(3):534. doi: 10.3390/nu14030534.
5
Evidence for Complementary and Alternative Therapies to Treat Glaucoma.
Semin Ophthalmol. 2023 Jan;38(1):85-91. doi: 10.1080/08820538.2022.2152704. Epub 2022 Dec 5.
6
Ginkgo biloba and its potential role in glaucoma.
Curr Opin Ophthalmol. 2018 Mar;29(2):116-120. doi: 10.1097/ICU.0000000000000459.
7
Potential role for Ginkgo biloba extract in the treatment of glaucoma.
Med Hypotheses. 2000 Feb;54(2):221-35. doi: 10.1054/mehy.1999.0025.
8
Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma.
Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):215-225. doi: 10.1097/APO.0000000000000279.
9
[Ginkgo biloba in glaucoma].
Oftalmologia. 2007;51(4):30-3.

引用本文的文献

2
Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.
PLoS One. 2025 Feb 14;20(2):e0314644. doi: 10.1371/journal.pone.0314644. eCollection 2025.
4
Complementary Approaches to Retinal Health Focusing on Diabetic Retinopathy.
Cells. 2023 Nov 24;12(23):2699. doi: 10.3390/cells12232699.
5
Herbal and Natural Treatments for the Management of the Glaucoma: An Update.
Biomed Res Int. 2023 Nov 17;2023:3105251. doi: 10.1155/2023/3105251. eCollection 2023.
6
Intravitreal injection of Huperzine A promotes retinal ganglion cells survival and axonal regeneration after optic nerve crush.
Front Cell Neurosci. 2023 May 24;17:1145574. doi: 10.3389/fncel.2023.1145574. eCollection 2023.
7
Three Major Causes of Metabolic Retinal Degenerations and Three Ways to Avoid Them.
Int J Mol Sci. 2023 May 13;24(10):8728. doi: 10.3390/ijms24108728.
8
Indian traditional medicinal plants in ophthalmic diseases.
Avicenna J Phytomed. 2022 Nov-Dec;12(6):566-575. doi: 10.22038/AJP.2022.20345.
9
Current situation and progress of drugs for reducing intraocular pressure.
Ther Adv Chronic Dis. 2022 Dec 2;13:20406223221140392. doi: 10.1177/20406223221140392. eCollection 2022.
10
Artificial intelligence in ophthalmology: A multidisciplinary approach.
Integr Med Res. 2022 Dec;11(4):100888. doi: 10.1016/j.imr.2022.100888. Epub 2022 Sep 20.

本文引用的文献

1
Comparison of Intraocular Pressure and Anterior Chamber Angle Changes between Pilocarpine and Laser Peripheral Iridotomy.
J Curr Glaucoma Pract. 2019 Jan-Apr;13(1):32-36. doi: 10.5005/jp-journals-10078-1245.
2
Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5904-5911. doi: 10.1167/iovs.18-24838.
3
Nutritional supplementation in the treatment of glaucoma: A systematic review.
Surv Ophthalmol. 2019 Mar-Apr;64(2):195-216. doi: 10.1016/j.survophthal.2018.09.005. Epub 2018 Oct 6.
4
5
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America.
Eur J Intern Med. 2018 Mar;49:2-6. doi: 10.1016/j.ejim.2018.01.001. Epub 2018 Jan 10.
6
Problems and Prospects: Public Health Regulation of Dietary Supplements.
Annu Rev Public Health. 2018 Apr 1;39:403-420. doi: 10.1146/annurev-publhealth-040617-013638. Epub 2017 Dec 22.
8
Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma.
Yale J Biol Med. 2017 Mar 29;90(1):111-118. eCollection 2017 Mar.
9
Neuroprotection for treatment of glaucoma in adults.
Cochrane Database Syst Rev. 2017 Jan 25;1(1):CD006539. doi: 10.1002/14651858.CD006539.pub4.
10
Neurodegeneration and Neuroprotection in Glaucoma.
Yale J Biol Med. 2016 Mar 24;89(1):73-9. eCollection 2016 Mar.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验